Factor Bioscience to Deliver Seven Presentations at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting

Factor Bioscience Inc., a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, announced its participation in the

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Joey Pisano ,Matt Angel ,American Society Of Gene Cell Therapy ,Prnewswire Factor Bioscience Inc ,A Library Of Novel Polyvalent ,Ionizable Lipids For Targeted Co ,Bioscience Inc ,American Society ,Cell Therapy ,Annual Meeting ,Kyle Garland ,Translational Science ,Exhibit Enhanced Immunosuppressive Activity ,Stealthing Features ,Raven Hinkel ,Transgene Expression ,Derived Tissue Specific Cells ,Taeyun Kim ,Targeted Gene Insertion Poster ,Opening Elements Mitigate Silencing ,Transgenes During ,Lymphocyte Differentiation ,Claire Aibel ,Gene Targeting ,Gene Correction New Technologies Poster ,Allogenic Cell Therapies ,Enhanced Safety Features ,Elizabeth Belcher ,Derived Macrophages Engineered ,Cancer Cell Killing ,Multi Cell Type Therapeutic Platform ,Ian Hay ,Immune Targeting ,Genetically Modified Cells ,Cell Therapies Poster ,Novel Polyvalent ,Ionizable Lipids ,Targeted Co Delivery ,Nonviral Therapeutic Gene Delivery ,Molecular Conjugates Poster ,Ionizable Lipids Enable Targeted Delivery ,Ariadna Lubinus ,Newswise ,Iotechnology Gene Cell Therapy ,Biotech ,Cell Biology ,Factor Bioscience ,